​

Funding Round

Series A - Apexigen

Series A - Apexigen

Investment Firm

Overview

Apexigen is a clinical-stage biopharmaceutical company focused on discovering and developing a new antibody therapeutics for oncology.

Announced Date

Aug 06, 2013

Funding Type

Series A

Highlights

Location

United States, North America

Social

Investor Lead

Amkey Ventures

Amkey Ventures

Amkey Ventures is a early_stage_venture firm.

Participant Investors

4

Investor Name
Participant InvestorThemes Investment Partners
Participant InvestorChina Development Industrial Bank (CDIB)
Participant InvestorAmkey Ventures
Participant InvestorSycamore Ventures

Round Details and Background

Apexigen raised $20000000 on 2013-08-06 in Series A

Apexigen is a clinical-stage biopharmaceutical company focused on discovering and developing a new antibody therapeutics for oncology.

Company Funding History

6

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Mar 24, 2020
Series C - Apexigen
6-65.0M
Aug 01, 2022
Post-IPO Equity - Apexigen
-15.0M
Jan 24, 2023
Post-IPO Equity - Apexigen
-2.8M
Aug 06, 2013
Series A - Apexigen
5-20.0M

Recent Activity

There is no recent news or activity for this profile.